Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYHS2402399	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs(4)	Generic Drug	2024-07-30		Shijiazhuang NO4 Pharmaceutical Co Ltd			view
CYHS2302687	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs(4)	Generic Drug	2023-10-11		Hunan Jiudian Pharmaceutical Co Ltd			view
CYHS2300422	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs(4)	Generic Drug	2023-02-09		Yichang Humanwell Pharmaceutical Co Ltd			view
CYHS2300423	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs(4)	Generic Drug	2023-02-09		Yichang Humanwell Pharmaceutical Co Ltd			view
JYHB2200081	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2022-02-15					view
JYHB2200082	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2022-02-15					view
JYHB2101341	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2021-08-19					view
JYHB2101340	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2021-08-19					view
JYHB2001373	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2020-08-21	辉瑞制药有限公司	Pfizer Pharmaceuticals Ltd	Filed	2020-09-02	view
JYHB2001321	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2020-08-21	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-12-30	view
JYHB2001374	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2020-08-21	辉瑞制药有限公司	Pfizer Pharmaceuticals Ltd	Filed	2020-09-02	view
JYHB2001320	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2020-08-10	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2020-12-30	view
JYHB1801285	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2018-11-12	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2018-12-05	view
JYHB1801286	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2018-11-12	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2018-12-05	view
JYHZ1700230	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	License Renew	2018-01-19	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2018-03-28	view
JYHZ1700231	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	License Renew	2018-01-19	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2018-03-28	view
JYHB1700682	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2017-05-13	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2017-07-18	view
JYHB1700683	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2017-05-13	辉瑞投资有限公司	Pfizer Investment Co Ltd	Certificate Issued	2017-07-18	view
JYHB1400901	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2014-07-04	Pfizer Italia s.r.l	Pfizer Italia SRL	Certificate Issued	2015-03-03	view
JYHB1400900	酒石酸托特罗定缓释胶囊	tolterodine tartrate	Capsules, extended release	Chemical Drugs	Supplementary Application	2014-07-04	Pfizer Italia s.r.l	Pfizer Italia SRL	Certificate Issued	2015-03-03	view